Clinical Trial Update: Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an anti-angiogenic approach for relapsed lymphoid malignancies, including Non-Hodgkin lymphoma, has been terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Non-Hodgkin's Lymphoma, Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-08-03